GW Henssler & Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
GW Henssler & Associates's ZBH Position: Q2 2025 in Review
GW Henssler & Associates sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,159 shares — an estimated $244K sold.
GW Henssler & Associates first reported a position in ZBH in Q1 2015 and held it in 16 quarters. The position peaked at $30.5M in Q2 2023. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.
- GW Henssler & Associates reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
- GW Henssler & Associates sold 2,159 Zimmer Biomet shares in Q2 2025, an estimated $244K.
- GW Henssler & Associates first reported a position in Zimmer Biomet in Q1 2015 and held it in 16 quarters.
- GW Henssler & Associates's Zimmer Biomet position peaked at $30.5M in Q2 2023.
- 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.
Based on GW Henssler & Associates's 13F filing for Q2 2025, filed 25 Jul 2025.